Stifel analyst Dae Gon Ha raised the price target on Mirum Pharamceuticals (NASDAQ: MIRM) to $70.00 (from $66.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Form SC 13G/A Mirum Pharmaceuticals, Filed by: BlackRock, Inc.November 12, 2024 11:45 AM Form 8-K Mirum Pharmaceuticals, For: Nov 12November 12, 2024 9:36 AM Form 10-Q Mirum Pharmaceuticals, For: Sep 30November 12, 2024 9:28 AM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q3 EPS by 15c ; Offers GuidanceNovember 12, 2024 8:06 AM Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 12, 2024 8:00 AM Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 8, 2024 6:30 PM